https://scholars.lib.ntu.edu.tw/handle/123456789/553694
標題: | Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease | 作者: | Chien S.-C. Chen C.-Y. Leu H.-B. Su C.-H. Yin W.-H. Tseng W.-K. YEN-WEN WU Lin T.-H. Chang K.-C. Wang J.-H. CHAU-CHUNG WU Yeh H.-I. Chen J.-W. |
公開日期: | 2017 | 卷: | 241 | 起(迄)頁: | 1-5 | 來源出版物: | International Journal of Cardiology | 摘要: | Objective Coronary heart disease (CHD) is a leading cause of death in developed countries. Exploration of indicators to identify high risk individuals who develop adverse outcomes despite stable baseline condition is important. This study is to evaluate the association between serum albumin concentration and cardiovascular (CV) outcomes in individuals of stable CHD. Methods Seven-hundred–thirty-four participants from Biosignature study, a nationwide prospective cohort study aimed to identity risk factors among patients with stable CHD, were enrolled for analysis. They were divided into low serum albumin group (baseline albumin concentration 3.5?g/dL, n?=?98) and normal albumin group (baseline albumin concentration ??3.5?g/dL, n?=?636). The relations between baseline albumin and adverse CV outcomes within 18?months of follow-up were analyzed. Results Compared baseline characteristics with normal albumin group, subjects in low albumin group are older, having more diabetic patients, lower hemoglobin level, lower estimated glomerular filtration rate, lower total cholesterol level, lower left ventricular ejection fraction, and higher blood glucose. While there is no significant difference of total CV events between two groups, low serum albumin concentration is associated with an increased risk of all-cause mortality (10.2% vs. 0.5%, p?0.001) and hard CV events (7.1% vs. 1.4%, p?0.001). The association remains significant after adjustments for confounders (all-cause mortality, HR: 6.81, 95% CI: 1.01–45.62; hard CV events, HR: 3.68, 95% CI: 1.03–13.19). Conclusions Low serum albumin concentration (3.5?g/dL) worsens prognosis of patients with stable CHD. ? 2017 Elsevier Ireland Ltd |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/553694 | ISSN: | 0167-5273 | DOI: | 10.1016/j.ijcard.2017.04.003 | SDG/關鍵字: | albumin; cholesterol; glucose; hemoglobin; biological marker; serum albumin; adult; adverse outcome; age; aged; albumin blood level; Article; cardiovascular disease; cardiovascular risk; cause of death; cholesterol blood level; cohort analysis; controlled study; diabetic patient; disease association; estimated glomerular filtration rate; female; follow up; glucose blood level; heart left ventricle ejection fraction; hemoglobin blood level; high risk patient; human; ischemic heart disease; major clinical study; male; mortality rate; priority journal; prognosis; prospective study; risk assessment; blood; clinical trial; coronary artery disease; diagnostic imaging; metabolism; middle aged; multicenter study; risk factor; Taiwan; very elderly; Aged; Aged, 80 and over; Biomarkers; Cohort Studies; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Serum Albumin; Taiwan |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。